This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Conklin, K. A. Search for Related Content PubMed PubMed Citation Articles by Conklin, K. A. Social Bookmarking                         What's this?

Chemotherapy-Associated Oxidative Stress: Impact on Chemotherapeutic Effectiveness

Jonsson Comprehensive Cancer Center, David Geffen School of Medicine, University of California, Los Angeles, kconklin{at}mednet.ucla.edu

Antineoplastic agents induce oxidative stress in biological systems. During cancer chemotherapy, oxidative stress-induced lipid peroxidation generates numerous electrophilic aldehydes that can attack many cellular targets. These products of oxidative stress can slow cell cycle progression of cancer cells and cause cell cycle checkpoint arrest, effects that may interfere with the ability of anticancer drugs to kill cancer cells. The aldehydes may also inhibit drug-induced apoptosis (programmed cell death) by inactivating death receptors and inhibiting caspase activity. These effects would also diminish the efficacy of the treatment. The use of anti-oxidants during chemotherapy may enhance therapy by reducing the generation of oxidative stress-induced aldehydes.

Key Words: antioxidants • apoptosis • chemotherapy • oxidative stress

Integrative Cancer Therapies, Vol. 3, No. 4, 294-300 (2004)
DOI: 10.1177/1534735404270335


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				B. D. Lawenda, K. M. Kelly, E. J. Ladas, S. M. Sagar, A. Vickers, and J. B. Blumberg Should Supplemental Antioxidant Administration Be Avoided During Chemotherapy and Radiation Therapy? J Natl Cancer Inst, June 4, 2008; 100(11): 773 - 783. [Abstract] [Full Text] [PDF]

				G. Huang, L. Mills, and L. L. Worth Expression of human glutathione S-transferase P1 mediates the chemosensitivity of osteosarcoma cells Mol. Cancer Ther., May 1, 2007; 6(5): 1610 - 1619. [Abstract] [Full Text] [PDF]

				B. Wessner, E.-M. Strasser, N. Koitz, C. Schmuckenschlager, N. Unger-Manhart, and E. Roth Green Tea Polyphenol Administration Partly Ameliorates Chemotherapy-Induced Side Effects in the Small Intestine of Mice J. Nutr., March 1, 2007; 137(3): 634 - 640. [Abstract] [Full Text] [PDF]

				R. W. Moss Should Patients Undergoing Chemotherapy and Radiotherapy Be Prescribed Antioxidants? Integr Cancer Ther, March 1, 2006; 5(1): 63 - 82. [Abstract] [PDF]

				K. I. Block and C. Gyllenhaal Commentary: The Pharmacological Antioxidant Amifostine--Implications of Recent Research for Integrative Cancer Care Integr Cancer Ther, December 1, 2005; 4(4): 329 - 351. [Abstract] [PDF]

				H.-V. Le, A. J. Minn, and J. Massague Cyclin-dependent Kinase Inhibitors Uncouple Cell Cycle Progression from Mitochondrial Apoptotic Functions in DNA-damaged Cancer Cells J. Biol. Chem., September 9, 2005; 280(36): 32018 - 32025. [Abstract] [Full Text] [PDF]

				K. I. Block Recapturing the Patient's Voice Integr Cancer Ther, June 1, 2005; 4(2): 107 - 109. [PDF]

				K. A. Conklin Coenzyme Q10 for Prevention of Anthracycline-Induced Cardiotoxicity Integr Cancer Ther, June 1, 2005; 4(2): 110 - 130. [Abstract] [PDF]

				K. I. Block Antioxidants and Cancer Therapy: Furthering the Debate Integr Cancer Ther, December 1, 2004; 3(4): 342 - 348. [Abstract] [PDF]